Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Consolidated Edison
ED
$39.8B
| $27.2M | 0.06% |
470,800
-402,442
| -46% | -$22.5M |
|
|
APC
352
DELISTED
Anadarko Petroleum
APC
| $27.1M | 0.06% |
+247,900
| New | +$25.2M |
|
|
FLY
353
DELISTED
Fly Leasing Limited
FLY
| $27.1M | 0.06% |
1,866,924
+28,824
| +2% | +$408K |
|
354
Synaptics
SYNA
$4.3B
| $27M | 0.06% |
298,227
+165,998
| +126% | +$11.2M |
|
355
AMC Global Media
AMCX
$487M
| $27M | 0.06% |
438,500
+404,392
| +1,186% | +$25.9M |
|
356
Flowserve
FLS
$10.1B
| $26.8M | 0.06% |
360,600
-80,224
| -18% | -$6.08M |
|
357
Spok Holdings
SPOK
$234M
| $26.8M | 0.06% |
1,740,984
+57,682
| +3% | +$919K |
|
|
ASEI
358
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $26.8M | 0.06% |
384,640
-4,473
| -1% | -$300K |
|
|
BRFS
359
DELISTED
BRF SA
BRFS
| $26.7M | 0.06% |
1,099,560
-1,059,000
| -49% | -$23.9M |
|
360
Teva Pharmaceuticals
TEVA
$43.2B
| $26.5M | 0.06% |
+504,663
| New | +$25.8M |
|
361
Service Corp International
SCI
$11.4B
| $26.4M | 0.06% |
1,271,788
-1,156,462
| -48% | -$22.6M |
|
362
Voya Financial
VOYA
$8.98B
| $26.1M | 0.06% |
718,500
+184,406
| +35% | +$6.59M |
|
363
Intuitive Surgical
ISRG
$141B
| $26.1M | 0.06% |
570,600
-405,900
| -42% | -$17.9M |
|
|
STRZA
364
DELISTED
Starz - Series A
STRZA
| $25.9M | 0.06% |
869,200
+407,692
| +88% | +$12.4M |
|
|
CLNY
365
DELISTED
Colony Capital, Inc.
CLNY
| $25.9M | 0.06% |
1,114,800
+8,690
| +0.8% | +$191K |
|
366
Carter's
CRI
$1.43B
| $25.9M | 0.06% |
375,300
+22,100
| +6% | +$1.61M |
|
367
Hasbro
HAS
$13.5B
| $25.6M | 0.06% |
483,200
-208,400
| -30% | -$11.3M |
|
368
Mativ Holdings
MATV
$699M
| $25.6M | 0.06% |
586,700
-77,600
| -12% | -$3.26M |
|
369
Ametek
AME
$58.9B
| $25.4M | 0.06% |
+486,750
| New | +$25.6M |
|
370
Affiliated Managers Group
AMG
$9.61B
| $25.1M | 0.06% |
122,000
-6,574
| -5% | -$1.27M |
|
|
DEST
371
DELISTED
Destination Maternity Corporation
DEST
| $25M | 0.06% |
1,098,076
+12,310
| +1% | +$301K |
|
|
PCH
372
DELISTED
PotlatchDeltic
PCH
| $25M | 0.06% |
603,453
-102,408
| -15% | -$4.02M |
|
|
SD
373
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $24.9M | 0.06% |
+3,476,578
| New | +$23.4M |
|
374
REX American Resources
REX
$1.43B
| $24.7M | 0.06% |
2,025,600
+426,000
| +27% | +$4.68M |
|
|
WLB
375
DELISTED
Westmoreland Coal Company
WLB
| $24.6M | 0.06% |
677,298
+343,999
| +103% | +$10.7M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.